Patents by Inventor Oliver Bocher

Oliver Bocher has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20180259523
    Abstract: The present invention relates to a diagnostic test for the detection of an E7 protein of a human papilloma virus in a biological sample wherein a sandwich ELISA as capture antibody at least two different rabbit monoclonal antibodies which bind to at least two different epitopes are used and as detection antibody at least two different polyclonal anti E7 antibodies are used.
    Type: Application
    Filed: October 30, 2015
    Publication date: September 13, 2018
    Applicants: Mikrogen GmbH, Österreichische Akademie der Wissenschaften
    Inventors: Pidder JANSEN-DÜRR, Oliver BÖCHER, Isabel KOCH, Erwin SOUTSCHEK
  • Publication number: 20100159445
    Abstract: The present invention concerns a method for the individual staging of the tumor disease of an individual cancer patient, a method for the individual decision on the method of treatment as well as a method for treating a cancer patient as well as their use in the treatment of various cancer diseases like colorectal tumor, prostate tumor, breast tumor, lung tumor, as primary tumors, tumor relapse and/or metastases. The present invention further provides a new prognosis factor in cancer treatment. This inventive method includes the step of analyzing at least one disseminated tumor cell present in a sample taken from a patient for the expression of at least one mRNA of at least one of growth factors, growth factor receptors and tumor associated transcripts.
    Type: Application
    Filed: March 1, 2007
    Publication date: June 24, 2010
    Applicant: Adnagen AG
    Inventors: Michael Lustig, Oliver Böcher, Winfried Albert
  • Publication number: 20080206866
    Abstract: The present invention relates to a reagent for prevention of time-dependent, induced expression in biological cells in a sample. It likewise relates to a method for this purpose and also to cell preparations treated in this manner, the reagent for prevention of time-dependence induced expression in biological cells in a sample ex vivo containing a formaldehyde donor.
    Type: Application
    Filed: March 22, 2006
    Publication date: August 28, 2008
    Applicant: ANDNAGEN AG
    Inventors: Veit Zieglschmid, Oliver Bocher, Winfried Albert